Jersey City, NJ, July 7, 2020 — In its ongoing commitment to maintaining compliance with ever-changing global clinical trial disclosure regulations, Boehringer Ingelheim has renewed
JERSEY CITY, NJ – June 30, 2020 – Healthcare Scene named Mike Wenger, Vice President of Patient Engagement for TrialScope, an honoree in the Patient
After building out a clinical trial matching API to help match patients discover the right trial for them, TrialScope VP of Patient Engagement Mike Wenger
As seen on ClinicalLeader.com – Posted Oct. 9, 2018 – Original Article Jan. 9, 2018 | By Ed Miseta, Chief Editor, Clinical Leader | The FDAAA (Food
As seen in CenterWatch.com – Posted Oct. 9, 2018 – Original Article Jan. 22, 2018 | A new FDA pilot program will publish information from sponsor-produced clinical
As seen in Outsourcing-Pharma.com – Posted Oct. 9, 2018 – Original Article April 5, 2018 | By Melissa Fassbender | Regulations are changing across the globe
As seen in Pharmaceutical Technology – Posted Oct. 9, 2018 – Original Article May 9, 2018 | By Ellen Daniel | The accessibility of clinical trial data
As seen on Outsourcing-Pharma.com – Posted Oct. 8, 2018 – Original Article May 17, 2018 | By Francine Lane | Francine Lane, vice president of global transparency at
As seen on AppliedClinicalTrialsOnline.com – Posted Oct. 9, 2018 – Original Article June 26, 2018 | By Thomas Wicks | A consistent and reliable approach to the increasing
Copyright © 2022 Pharma Intelligence UK Limited
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 – 12 St. James’s Square, London, England, SW1Y 4LB. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group
